MediSave withdrawal limit for HIV drugs to rise, family accounts can be used

Singapore is taking a significant step forward in its commitment to combating HIV by enhancing financial support for patients undergoing antiretroviral therapy. Starting June 1, the monthly MediSave withdrawal limit for HIV drugs will be raised from S$550 to S$850. This increase, announced by Minister of State for Health Rahayu Mahzam, is designed to alleviate the financial burden on individuals living with HIV, ensuring they can access and adhere to their life-saving treatment.

“

This encourages early engagement with clinical services and reduces the likelihood that individuals will fall through the cracks between testing and care.

Beyond the increased withdrawal limit, a crucial policy change allows patients to utilize their family members' MediSave accounts for these treatments. This measure reflects a compassionate approach, recognizing that HIV treatment is a shared responsibility and that family support can play a vital role in a patient's well-being and recovery. By reducing financial barriers at the point of diagnosis, Singapore aims to encourage prompt engagement with clinical services, thereby preventing individuals from falling through the cracks between testing and care. This proactive stance is essential in managing the epidemic effectively.

“

The year-on-year increase in cases in 2025 shows Singapore cannot rest on its laurels.

The announcement comes as Singapore continues to monitor HIV trends, with new cases showing fluctuations but an overall decrease in recent years. However, the rise in late-stage diagnoses in 2025 underscores the persistent need to reduce stigma and misinformation that deter individuals from seeking timely testing. The government's efforts, including the availability of self-testing kits, are expanding testing options and making it more accessible and private. Singapore's progress towards the UNAIDS 95-95-95 targets demonstrates a strong commitment to ending the HIV/AIDS epidemic by 2030, with ongoing efforts to address delayed diagnoses and ensure seamless access to treatment.

“

These include reducing delayed diagnosis, improving linkage to care for those who test positive, and ensuring that patients are able to access HIV treatment without financial barriers.